Phase 1b/2 Study to Evaluate Novel Combinations With Oleclumab (MEDI9447) in Previously Treated Advanced EGFRm NSCLC

Rizvi, N; Sim, C; Goldberg, S; Papadimitrakopoulou, V; Camidge, DR; Patel, S; Marrone, K; Kim, S; Kim, D; Hsieh, H; Mueller, N; Kumar, R; Englert, J; Park, K

JOURNAL OF THORACIC ONCOLOGY, 2018; 13 (10): S930